Rheumatoid Arthritis Clinical Trials in Houston

Showing 2261-2280 of 3,412 trials

Safety of 1 g and 2 g of Cefazolin in Pediatric Subjects

NCT03231228

This is a Phase 4, open-label, single-dose, parallel-group, multicenter, safety study of cefazolin (1 g or 2 g) in pediatric subjects between 10 and 17 years of age (inclusive) scheduled for surgery.

Postoperative Infection

B. Braun Medical Inc.61 participantsStarted Nov 2017

Little Rock, Arkansas, United States • Columbia, Missouri, United States • Dallas, Texas, United States +2 more locations

COMPLETEDPhase 3< 1 mile

A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

NCT03231800

A study to evaluate the efficacy and safety of dasotraline in children 6 to 12 years of age with Attention-Deficit Hyperactivity Disorder (ADHD) in a simulated classroom setting.

Attention-Deficit Hyperactivity Disorder (ADHD)

Sumitomo Pharma America, Inc.95 participantsStarted Jul 2017

Newport Beach, California, United States • Bradenton, Florida, United States • Maitland, Florida, United States +5 more locations

COMPLETED< 1 mile

Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)

NCT02014896

The proposed study will validate the clinical use of new biomarker blood tests to identify blood components that may differentiate between diverse stroke etiologies and clinical outcomes as listed below: 1. Differentiate between cardioembolic and large artery atherosclerotic ischemic strokes, when hemorrhagic stroke is ruled out. 2. In cases of ischemic strokes of unknown or "cryptogenic" etiology, determine the ability of biomarker blood tests to predict etiology between cardioembolic and large artery atherosclerotic. 3. In cases of cardioembolic ischemic stroke, further differentiation of cardioembolic ischemic strokes into those caused by atrial fibrillation (AF) and those not caused by AF. 4. Differentiate "transient ischemic attacks" (TIAs) from acute ischemic strokes. 5. Differentiate TIAs from non-ischemic "transient neurological events" (TNE) with similar symptoms.

Ischemic StrokeAtrial FibrillationTransient Ischemic Attacks+4 more

Ischemia Care LLC1,750 participantsStarted Dec 2013

Sacramento, California, United States • San Francisco, California, United States • San Francisco, California, United States +19 more locations

Safety of 1 g and 2 g of Cefazolin in Pediatric Subjects

A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)

Rheumatoid Arthritis Trials in Other Cities

Study of the Penumbra Coil 400 System to Treat Aneurysm

Viral Triggers in Pediatric Lung Transplantation

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis

Clinical Investigation of the Next Generation Intraocular Lens

Postoperative Respiratory Abnormalities

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain

Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

Intra-oral Treatment of OLP With Rivelin®-CLO Patches

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis

Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

ClarVista HARMONI Toric Trial With Intraoperative Exchange

Other Conditions in Houston